<- Go Home
China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People’s Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd.
Market Cap
HKD 5.8B
Volume
515.7K
Cash and Equivalents
HKD 6.2B
EBITDA
HKD 1.1B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
HKD 3.2B
Profit Margin
75.21%
52 Week High
HKD 10.14
52 Week Low
HKD 6.92
Dividend
7.09%
Price / Book Value
0.80
Price / Earnings
5.29
Price / Tangible Book Value
0.82
Enterprise Value
-HKD 48.2M
Enterprise Value / EBITDA
-0.04
Operating Income
HKD 944.7M
Return on Equity
15.81%
Return on Assets
6.29
Cash and Short Term Investments
HKD 6.2B
Debt
HKD 351.1M
Equity
HKD 7.3B
Revenue
HKD 4.2B
Unlevered FCF
HKD 828.3M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium